Dr. Lei Zhu and Maj. Kelly Ray, Walter Reed Army Institute of Research, Clinical Trials Center, research coordinators prepare samples prior to the RV575 research study, Sept. 27, 2022. In October, the Military HIV Research Program will launch the phase 1 study, evaluating varying doses of the Army's novel ALFQ adjuvant in a candidate HIV vaccine to determine the optimal adjuvant dosage level.

---

Size: 8192px × 5464px
Photo credit: © Operation 2022 / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: ctc, hiv, research, study, wrair